Next-Generation Farnesoid X Receptor Agonists in NASH Treatment: Are We There Yet?

Gastroenterology. 2023 Aug;165(2):513-514. doi: 10.1053/j.gastro.2023.03.213. Epub 2023 Mar 21.
No abstract available

Publication types

  • Comment

MeSH terms

  • Bile Acids and Salts
  • Chenodeoxycholic Acid / therapeutic use
  • Humans
  • Non-alcoholic Fatty Liver Disease* / diagnosis
  • Non-alcoholic Fatty Liver Disease* / drug therapy

Substances

  • Bile Acids and Salts
  • Chenodeoxycholic Acid